Farther Finance Advisors’s Compass Therapeutics CMPX Stock Holding History

Farther Finance Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$338	Sell	325 -939	-74%	-$1.94K	﹤0.01%	5807
2026 Q2	$2.75K	Buy	1,264 +609	+93%	+$1.8K	﹤0.01%	5048
2026 Q1	$3.56K	Sell	655 -25	-4%	-$144	﹤0.01%	4667
2025 Q4	$3.65K	Buy	680 +292	+75%	+$1.35K	﹤0.01%	4462
2025 Q3	$1.36K	Buy	+388	New	+$1.23K	﹤0.01%	4271

Other funds holding CMPX

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's CMPX Position: Q3 2026 in Review

Farther Finance Advisors reduced its Compass Therapeutics (CMPX) stake by 74% in Q3 2026, selling an estimated $1.94K and leaving 325 shares worth $338. The position accounts for ﹤0.01% of the portfolio, ranked #5807.

Farther Finance Advisors first reported a position in CMPX in Q3 2025 and has held it in 5 quarters since. The position peaked at $3.65K in Q4 2025. 2 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.

Farther Finance Advisors held 325 shares of Compass Therapeutics worth $338 as of Q3 2026.
Farther Finance Advisors sold 939 Compass Therapeutics shares in Q3 2026, an estimated $1.94K.
Compass Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5807 holding.
Farther Finance Advisors first reported a position in Compass Therapeutics in Q3 2025 and has held it in 5 quarters since.
Farther Finance Advisors's Compass Therapeutics position peaked at $3.65K in Q4 2025.
2 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.